Erste Asset Management GmbH »

Blueprint Medicines shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 25k 92.55

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Unitedhealth Group Incorporated Common Stock (UNH)
Netflix Common Stock (NFLX)
Visa Common Stock (V)
Adobe Common Stock (ADBE)
The Progressive Corporation Common Stock (PGR)
Broadcom Common Stock (AVGO)
Agios Pharmaceuticals Common Stock (AGIO)
Lam Research Corporation Common Stock (LRCX)
Kla Corporation Common Stock (KLAC)
Amazon.com Common Stock (AMZN)

View all positions for Erste Asset Management GmbH

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines